Viewing Study NCT01823835


Ignite Creation Date: 2025-12-24 @ 10:04 PM
Ignite Modification Date: 2026-03-02 @ 8:03 PM
Study NCT ID: NCT01823835
Status: TERMINATED
Last Update Posted: 2021-06-18
First Post: 2013-03-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
Sponsor: Genentech, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: GO29642
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators